share_log

Hainan Haiyao (SZSE:000566) Sheds CN¥363m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Five Years

Hainan Haiyao (SZSE:000566) Sheds CN¥363m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Five Years

海南海药(深圳证券交易所代码:000566)下跌3.63亿元人民币,公司收益和投资者回报率在过去五年中一直呈下降趋势
Simply Wall St ·  04/17 21:39

We think intelligent long term investing is the way to go. But along the way some stocks are going to perform badly. For example the Hainan Haiyao Co., Ltd. (SZSE:000566) share price dropped 61% over five years. That's an unpleasant experience for long term holders. We also note that the stock has performed poorly over the last year, with the share price down 33%. Shareholders have had an even rougher run lately, with the share price down 17% in the last 90 days.

我们认为明智的长期投资是必经之路。但在此过程中,一些股票将表现不佳。例如,海南海药股份有限公司(深圳证券交易所代码:000566)的股价在五年内下跌了61%。对于长期持有者来说,这是一种不愉快的经历。我们还注意到,该股去年表现不佳,股价下跌了33%。股东们最近的表现更加艰难,股价在过去90天中下跌了17%。

After losing 7.6% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance.

在上周下跌7.6%之后,值得研究该公司的基本面,看看我们可以从过去的表现中推断出什么。

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

不可否认,市场有时是有效的,但价格并不总是能反映潜在的业务表现。通过比较每股收益(EPS)和一段时间内的股价变化,我们可以了解投资者对公司的态度是如何随着时间的推移而变化的。

During five years of share price growth, Hainan Haiyao moved from a loss to profitability. Most would consider that to be a good thing, so it's counter-intuitive to see the share price declining. Other metrics may better explain the share price move.

在五年的股价增长中,海南海药从亏损转为盈利。大多数人会认为这是一件好事,因此股价下跌是违反直觉的。其他指标可以更好地解释股价走势。

It could be that the revenue decline of 8.6% per year is viewed as evidence that Hainan Haiyao is shrinking. This has probably encouraged some shareholders to sell down the stock.

每年8.6%的收入下降可能被视为海南海药正在萎缩的证据。这可能鼓励了一些股东抛售该股。

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

下图显示了收入和收入随时间推移的跟踪情况(如果您点击图片,可以看到更多细节)。

earnings-and-revenue-growth
SZSE:000566 Earnings and Revenue Growth April 18th 2024
SZSE: 000566 2024年4月18日收益和收入增长

Take a more thorough look at Hainan Haiyao's financial health with this free report on its balance sheet.

通过这份免费的资产负债表报告,更全面地了解海南海药的财务状况。

A Different Perspective

不同的视角

We regret to report that Hainan Haiyao shareholders are down 33% for the year. Unfortunately, that's worse than the broader market decline of 20%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 10% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For instance, we've identified 1 warning sign for Hainan Haiyao that you should be aware of.

我们遗憾地报告,海南海药股东今年下跌了33%。不幸的是,这比整个市场20%的跌幅还要严重。但是,可能只是股价受到了更广泛的市场紧张情绪的影响。如果有很好的机会,可能值得关注基本面。遗憾的是,去年的业绩结束了糟糕的表现,股东在五年内每年面临10%的总亏损。我们意识到罗斯柴尔德男爵曾说过,投资者应该 “在街头流血时买入”,但我们警告说,投资者应首先确保他们购买的是高质量的企业。尽管市场状况可能对股价产生的不同影响值得考虑,但还有其他因素更为重要。例如,我们已经确定了海南海药的1个警告标志,你应该注意。

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

对于那些喜欢寻找中奖投资的人来说,这份最近有内幕收购的成长型公司的免费名单可能只是门票。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发